A vision to the future: value-based laboratory medicine

IF 3.8 2区医学 Q1 MEDICAL LABORATORY TECHNOLOGY

Clinical chemistry and laboratory medicine Pub Date : 2024-09-11 DOI:10.1515/cclm-2024-1022

Mario Plebani, Janne Cadamuro, Pieter Vermeersch, Snežana Jovičić, Tomris Ozben, Tommaso Trenti, Brian McMillan, Christopher R. Lowe, Jochen Lennerz, Elizabeth Macintyre, Carlo Gabelli, Sverre Sandberg, Andrea Padoan, Joesph R. Wiencek, Giuseppe Banfi, Ira M. Lubin, Matthias Orth, Anna Carobene, Tomáš Zima, Christa M. Cobbaert, Ron H.N. van Schaik, Giuseppe Lippi

{"title":"A vision to the future: value-based laboratory medicine","authors":"Mario Plebani, Janne Cadamuro, Pieter Vermeersch, Snežana Jovičić, Tomris Ozben, Tommaso Trenti, Brian McMillan, Christopher R. Lowe, Jochen Lennerz, Elizabeth Macintyre, Carlo Gabelli, Sverre Sandberg, Andrea Padoan, Joesph R. Wiencek, Giuseppe Banfi, Ira M. Lubin, Matthias Orth, Anna Carobene, Tomáš Zima, Christa M. Cobbaert, Ron H.N. van Schaik, Giuseppe Lippi","doi":"10.1515/cclm-2024-1022","DOIUrl":null,"url":null,"abstract":"The ultimate goal of value-based laboratory medicine is maximizing the effectiveness of laboratory tests in improving patient outcomes, optimizing resources and minimizing unnecessary costs. This approach abandons the oversimplified notion of test volume and cost, in favor of emphasizing the clinical utility and quality of diagnostic tests in the clinical decision-making. Several key elements characterize value-based laboratory medicine, which can be summarized in some basic concepts, such as organization of in vitro diagnostics (including appropriateness, integrated diagnostics, networking, remote patient monitoring, disruptive innovations), translation of laboratory data into clinical information and measurable outcomes, sustainability, reimbursement, ethics (e.g., patient empowerment and safety, data protection, analysis of big data, scientific publishing). Education and training are also crucial, along with considerations for the future of the profession, which will be largely influenced by advances in automation, information technology, artificial intelligence, and regulations concerning in vitro diagnostics. This collective opinion paper, composed of summaries from presentations given at the two-day European Federation of Laboratory Medicine (EFLM) Strategic Conference “A vision to the future: value-based laboratory medicine” (Padova, Italy; September 23–24, 2024), aims to provide a comprehensive overview of value-based laboratory medicine, projecting the profession into a more clinically effective and sustainable future.","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":"59 1","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical chemistry and laboratory medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1515/cclm-2024-1022","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

The ultimate goal of value-based laboratory medicine is maximizing the effectiveness of laboratory tests in improving patient outcomes, optimizing resources and minimizing unnecessary costs. This approach abandons the oversimplified notion of test volume and cost, in favor of emphasizing the clinical utility and quality of diagnostic tests in the clinical decision-making. Several key elements characterize value-based laboratory medicine, which can be summarized in some basic concepts, such as organization of in vitro diagnostics (including appropriateness, integrated diagnostics, networking, remote patient monitoring, disruptive innovations), translation of laboratory data into clinical information and measurable outcomes, sustainability, reimbursement, ethics (e.g., patient empowerment and safety, data protection, analysis of big data, scientific publishing). Education and training are also crucial, along with considerations for the future of the profession, which will be largely influenced by advances in automation, information technology, artificial intelligence, and regulations concerning in vitro diagnostics. This collective opinion paper, composed of summaries from presentations given at the two-day European Federation of Laboratory Medicine (EFLM) Strategic Conference “A vision to the future: value-based laboratory medicine” (Padova, Italy; September 23–24, 2024), aims to provide a comprehensive overview of value-based laboratory medicine, projecting the profession into a more clinically effective and sustainable future.

查看原文本刊更多论文

未来愿景：基于价值的实验室医学

以价值为基础的检验医学的最终目标是最大限度地发挥检验在改善患者预后、优化资源和减少不必要费用方面的作用。这种方法摒弃了过于简单的检验量和成本概念，转而强调诊断检测在临床决策中的临床效用和质量。以价值为基础的检验医学有几个关键要素，可归纳为一些基本概念，如体外诊断的组织（包括适当性、综合诊断、联网、远程患者监测、颠覆性创新）、将实验室数据转化为临床信息和可衡量的结果、可持续性、报销、伦理（如患者赋权和安全、数据保护、大数据分析、科学出版）。教育和培训也至关重要，同时还要考虑到这一行业的未来，因为自动化、信息技术、人工智能和体外诊断相关法规的进步将在很大程度上影响这一行业的未来。在为期两天的欧洲检验医学联合会（EFLM）战略会议 "展望未来：以价值为基础的检验医学"（意大利帕多瓦，2024 年 9 月 23-24 日）上发表的演讲摘要组成了这份集体观点文件，旨在全面概述以价值为基础的检验医学，预测该行业将迈向更有效的临床和可持续发展的未来。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical chemistry and laboratory medicine 医学-医学实验技术

CiteScore

11.30

自引率

16.20%

发文量

306

审稿时长

3 months

期刊介绍： Clinical Chemistry and Laboratory Medicine (CCLM) publishes articles on novel teaching and training methods applicable to laboratory medicine. CCLM welcomes contributions on the progress in fundamental and applied research and cutting-edge clinical laboratory medicine. It is one of the leading journals in the field, with an impact factor over 3. CCLM is issued monthly, and it is published in print and electronically. CCLM is the official journal of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and publishes regularly EFLM recommendations and news. CCLM is the official journal of the National Societies from Austria (ÖGLMKC); Belgium (RBSLM); Germany (DGKL); Hungary (MLDT); Ireland (ACBI); Italy (SIBioC); Portugal (SPML); and Slovenia (SZKK); and it is affiliated to AACB (Australia) and SFBC (France). Topics: - clinical biochemistry - clinical genomics and molecular biology - clinical haematology and coagulation - clinical immunology and autoimmunity - clinical microbiology - drug monitoring and analysis - evaluation of diagnostic biomarkers - disease-oriented topics (cardiovascular disease, cancer diagnostics, diabetes) - new reagents, instrumentation and technologies - new methodologies - reference materials and methods - reference values and decision limits - quality and safety in laboratory medicine - translational laboratory medicine - clinical metrology Follow @cclm_degruyter on Twitter!